Hypovitaminosis D and Metabolic Syndrome in Postmenopausal Women
Author | Abuhijleh, Haya |
Author | Alkhatib, Dana |
Author | Ganji, Vijay |
Available date | 2022-10-28T11:49:30Z |
Publication Date | 2022-10-14 |
Publication Name | Healthcare |
Identifier | http://dx.doi.org/10.3390/healthcare10102026 |
Citation | Abuhijleh, H.; Alkhatib, D.; Ganji, V. Hypovitaminosis D and Metabolic Syndrome in PostmenopausalWomen. Healthcare 2022, 10, 2026. https://doi.org/ 10.3390/healthcare10102026 |
Abstract | Metabolic syndrome (MetSyn) is a precursor for several cardiometabolic diseases. The prevalence of MetSyn is higher in postmenopausal women compared to premenopausal women. The role of vitamin D in postmenopausal women is not clearly understood. Hypovitaminosis D is more prevalent in postmenopausal women compared to premenopausal women. For this review, Pubmed, Cochrane, SCOPUS, Embase, and Google Scholar databases were searched up to August 2022. Findings from one randomized controlled trial (RCT) and ten cross-sectional studies were included in this review. Several cross-sectional studies (8 out of 10 reviewed) unequivocally demonstrated an inverse association between serum 25-hydroxyvitamin D concentrations and MetSyn. However, RCTs are severely lacking in the effect of vitamin D intake on the biomarkers of MetSyn and the prevalence of MetSyn. Therefore, caution should be used in recommending mega doses of vitamin D supplements for postmenopausal women because of the potential adverse effects associated with this vitamer. |
Sponsor | Qatar university Internal Grant No. QUST-2-CHS-2022-730. |
Language | en |
Publisher | MDPI |
Subject | 25-hydroxyvitamin D hypovitaminosis D insulin resistance metabolic syndrome postmenopausal women |
Type | Article Review |
Issue Number | 10 |
Volume Number | 10 |
ESSN | 2227-9032 |
Files in this item
This item appears in the following Collection(s)
-
Human Nutrition [373 items ]